Citation Impact
Citing Papers
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee
2012
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
A RANDOMISED, DOUBLE‐BLIND STUDY OF ITRACONAZOLE VERSUS PLACEBO IN THE TREATMENT AND PREVENTION OF ORAL OR OESOPHAGEAL CANDIDOSIS IN PATIENTS WITH HIV INFECTION
1999
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Super-resolution imaging of nuclear import of adeno-associated virus in live cells
2015
Engineering precision nanoparticles for drug delivery
2020 Standout
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung Disease
2007
Vulvovaginal candidosis
2007 Standout
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Mesoporous silica nanoparticles in biomedical applications
2012 StandoutNobel
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
2023 StandoutNobel
A Prospective, Randomized Trial Examining the Efficacy and Safety of Clarithromycin in Combination with Ethambutol, Rifabutin, or Both for the Treatment of Disseminated Mycobacterium avium Complex Disease in Persons with Acquired Immunodeficiency Syndrome
2003
Isolation and evaluation of novel adeno-associated virus sequences from porcine tissues
2009
Development of next generation adeno-associated viral vectors capable of selective tropism and efficient gene delivery
2015
Association between Pulmonary Function and Sputum Biomarkers in Cystic Fibrosis
2007
A 10 Patient Case Report on the Impact of Plasmapheresis Upon Neutralizing Factors Against Adeno-associated Virus (AAV) Types 1, 2, 6, and 8
2011
Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV–Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis
2013 StandoutNobel
Stimuli-responsive nanocarriers for drug delivery
2013 Standout
Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re-administration in mice
2007
Osteoarthritis
2015 Standout
Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery
2021 StandoutNobel
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Generation of Novel AAV Variants by Directed Evolution for Improved CFTR Delivery to Human Ciliated Airway Epithelium
2009
Cancer genes and the pathways they control
2004 Standout
Evolution of Antifungal Susceptibility amongCandidaSpecies Isolates Recovered from Human Immunodeficiency Virus–Infected Women Receiving Fluconazole Prophylaxis
2001
Non-viral vectors for gene-based therapy
2014 Standout
The Evolution ofCandidaSpecies and Fluconazole Susceptibility among Oral and Vaginal Isolates Recovered from Human Immunodeficiency Virus (HIV)–Seropositive and At‐Risk HIV‐Seronegative Women
2001
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
A Randomized, Double‐Blind, Double‐Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients
2001
Echinocandin antifungal drugs
2003 Standout
In vivo genome editing using Staphylococcus aureus Cas9
2015 StandoutNature
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Directed evolution of adeno-associated virus yields enhanced gene delivery vectors
2006
Precise hit: adeno-associated virus in gene targeting
2005
Scalable Downstream Strategies for Purification of Recombinant Adeno- Associated Virus Vectors in Light of the Properties
2015
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
2020 Standout
Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges
2011
Overview of the clinical efficacy of investigational anticancer drugs
2003
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
Magnetic Nanoparticles Enhance Adenovirus Transduction In Vitro and In Vivo
2011
The Future of In Utero Gene Therapy
2020
Association of Adherence toMycobacterium aviumComplex Prophylaxis and Antiretroviral Therapy with Clinical Outcomes in Acquired Immunodeficiency Syndrome
2002
Recombinant AAV Viral Vectors Pseudotyped with Viral Capsids from Serotypes 1, 2, and 5 Display Differential Efficiency and Cell Tropism after Delivery to Different Regions of the Central Nervous System
2004
Induction of Immune Tolerance to Foreign Protein via Adeno-Associated Viral Vector Gene Transfer in Mid-Gestation Fetal Sheep
2017
Immunological recovery and antiretroviral therapy in HIV-1 infection
2006
Evidence-Based Knee Injections for the Management of Arthritis
2012
Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis
2018
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals
2005
In utero CRISPR-mediated therapeutic editing of metabolic genes
2018
Cystic fibrosis
2009
Optogenetics in Neural Systems
2011 Standout
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
DisseminatedMycobacterium aviumComplex Disease among Patients Infected with Human Immunodeficiency Virus, 1985–2000
2001
Excellent Outcome of Lamivudine Treatment in Patients With Chronic Renal Failure and Hepatitis B Virus Infection
2003
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Compacted DNA Nanoparticles Administered to the Nasal Mucosa of Cystic Fibrosis Subjects Are Safe and Demonstrate Partial to Complete Cystic Fibrosis Transmembrane Regulator Reconstitution
2004
Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial
2017
Prevalence of Neutralizing Antibodies Against Adeno-Associated Virus (AAV) Types 2, 5, and 6 in Cystic Fibrosis and Normal Populations: Implications for Gene Therapy Using AAV Vectors
2006
Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
2010
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
Optogenetic Dissection of Entorhinal-Hippocampal Functional Connectivity
2013 StandoutScienceNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Diagnosis and Treatment of Hip and Knee Osteoarthritis
2021 Standout
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Current and Emerging Azole Antifungal Agents
1999 Standout
Nonviral Vectors for Gene Delivery
2008 Standout
995. Effect of Viral Dose on Neutralizing Antibody Response and Transgene Expression after AAV1 Vector Re-Administration in Mice
2006
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 StandoutNobel
Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy
2005
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
1998
In Vivo Potency Assay for Adeno-Associated Virus–Based Gene Therapy Vectors Using AAVrh.10 as an Example
2018
Ionizable lipid nanoparticles for in utero mRNA delivery
2021 StandoutNobel
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy
2015
Interventions for enhancing medication adherence
2014 Standout
Guidelines for the Management of Chronic Kidney Disease in HIV-Infected Patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America
2005
Aspergillus fumigatusand Aspergillosis
1999 Standout
Viral Vectors for Gene Therapy: Translational and Clinical Outlook
2015
Possible Link Between Toxoplasma Gondii and the Anosmia Associated With Neurodegenerative Diseases
2014
Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
2021 StandoutNobel
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Randomized, Double-Blind, Multicenter Study of Caspofungin versus Amphotericin B for Treatment of Oropharyngeal and Esophageal Candidiases
2002
Radioactive liposomes
2008
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery
2017 StandoutNobel
Intranasal Antibody Gene Transfer in Mice and Ferrets Elicits Broad Protection Against Pandemic Influenza
2013
Works of Alison E. Heald being referenced
Single-joint Outcome Measures: Preliminary Validation of Patient-reported Outcomes and Physical Examination
2010
A multicenter phase II study of tgDCC‐E1A for the intratumoral treatment of patients with recurrent head and neck squamous cell carcinoma
2002
Repeated Adeno-Associated Virus Serotype 2 Aerosol-Mediated Cystic Fibrosis Transmembrane Regulator Gene Transfer to the Lungs of Patients With Cystic Fibrosis
2004
Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor α antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study
2008
Protease inhibitors are associated with a slowed progression of HIV-related renal diseases
2002
Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patientsreceiving long-term continuous versus intermitent fluconazole therapy
1996
Taste and smell losses in HIV infected patients
1995
Phase I Trial of Intranasal and Endobronchial Administration of a Recombinant Adeno-Associated Virus Serotype 2 (rAAV2)-CFTR Vector in Adult Cystic Fibrosis Patients: A Two-Part Clinical Study
2003
Repeated Aerosolized AAV-CFTR for Treatment of Cystic Fibrosis: A Randomized Placebo-Controlled Phase 2B Trial
2007
Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction
1996
Discontinuation of Mycobacterium avium Complex Prophylaxis in Patients with Antiretroviral Therapy–Induced Increases in CD4+ Cell Count
2000